Schering-Plough has announced that Asmanex Twisthaler 110mcg is now available in pharmacies nationwide.
Subscribe to our email newsletter
Asmanex is indicated for the maintenance treatment of asthma as prophylactic therapy in patients four years of age and older, and is said to be the first and only once-daily inhaled corticosteroid inhaler approved for this use in children as young as four.
Asmanex was approved for children ages four to 11 by the FDA in February 2008. It is not indicated for the relief of sudden asthma symptoms or in children less than four years of age.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.